Skip to Content


Alliance in Brazil

Promise - Summer 2012

MD Anderson and Hospital Israelita Albert Einstein to collaborate

By La Chanda Jenkins

Dan Fontaine, senior vice president for business affairs,
finalizes an agreement with Claudio Lottenberg, M.D., 
president of the Sociedade Beneficente Israelita Brasileira
Albert Einstein.
Photo courtesy of Hospital Israelita Albert Einstein

MD Anderson recently announced an agreement with Hospital Israelita Albert Einstein (HIAE) in São Paulo, Brazil, creating an alliance to develop a comprehensive, multidisciplinary oncology program at the hospital.

The 10-year agreement calls for MD Anderson to provide its specialized expertise to help transform HIAE’s oncology program into the premier cancer care center in South America. It will  focus on four key initiatives: patient care, research, education and prevention ― obviously in line with MD Anderson’s own mission areas.

Brazil, which reports more than 520,000 new cancer cases a year, represents an opportunity to make a significant and lasting impact on cancer care delivery, says Amy Hay, interim vice president for global business development.

“Hospital Israelita Albert Einstein will incorporate MD Anderson’s multidisciplinary approach to address the cancer burden in Brazil, and MD Anderson will advance its mission by extending its reach to South America,” says Hay. “Most important, patients in Brazil will have a powerful force to aid in their fight against cancer.”

The agreement represents an expansion of a long-standing relationship between the two institutions. HIAE became MD Anderson’s first formal sister institution in 2002, leading to frequent academic exchanges. Prior agreements between 
MD Anderson and HIAE, starting in 2008, have resulted in the launch of multidisciplinary breast and genitourinary clinics, as well as a redesign of oncology facilities at the HIAE.

© 2015 The University of Texas MD Anderson Cancer Center